Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm
Abstract
The efficacy of intravenous flecainide acetate (maximum 2 mg/kg or 150 mg given at a rate of 15 mg/min) was assessed in patients with acute supraventricular tachycardia (SVT) (within 24 hours). Fifty patients were studied, 46 with spontaneous SVT and 4 with induced SVT at electrophysiologic assessment. Conversion to sinus rhythm was achieved within 45 minutes in 76%: in 25 patients with atrial fibrillation (76% conversion), 15 with atrioventricular (AV) nodal or AV reentrant tachycardia (100% conversion) and 10 with atrial flutter or atrial reentrant tachycardia (40% conversion). Adverse effects were noted in 21 patients (42%): paresthesia in 9, drowsiness in 8, nausea in 2, accelerated ventricular rate in 5, ventricular tachycardia in 1, sinus bradycardia in 1 and hypotension in 5. Adverse effects were associated with larger dosage and atrial flutter or atrial reentrant tachycardia. Thus, flecainide acetate is effective in converting to sinus rhythm acute atrial fibrillation and AV nodal and AV reentrant tachycardias, but not atrial flutter or atrial reentrant tachycardia.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The Na+ channel blocking effect of class Ia and Ic drugs may slow atrial rate and lead to 1:1 AV conduction at rates ≤200/min, often with QRS widening mimicking VT.
“The Na + channel blocking effect of class Ia and Ic drugs may slow atrial rate and lead to 1:1 AV conduction at rates ≤200/min, often with QRS widening that mimics ventricular tachycardia (Figure 12).150”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [150]
Class Ic antiarrhythmic drugs should not be used without AV blocking agents because of risk of slowing atrial rate and leading to 1:1 AV conduction.
“Class Ic antiarrhythmic drugs should not be used in the absence of AV blocking agents because of the risk of slowing atrial rate, and leading to 1:1 AV conduction.150,151”
From European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE) (2017) · cites this paper as [150]
Cites
Waxman, H. L., Myerburg, R. J., Appel, R. A., & Sung, R. J. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-1-1 · Cited by 209 · see citing works
Conard, G. J., & Ober, R. E. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90501-0 · Cited by 203 · see citing works
Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion
Fenster, P. E., Comess, K. A., Marsh, R., Katzenberg, C., & Hager, W. D. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90692-0 · Cited by 157 · see citing works
Hellestrand, K. J., Bexton, R. S., Nathan, A. W., Spurrell, R. A., & Camm, A. J. (1982) · Heart · doi:10.1136/hrt.48.2.140 · Cited by 142 · see citing works
Hellestrand, K. J., Nathan, A. W., Bexton, R. S., Spurrell, R. A., & Camm, A. J. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80131-3 · Cited by 81 · see citing works
Electrophysiologic properties of flecainide acetate
Estes, N. A. M., Garan, H., & Ruskin, J. N. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90498-3 · Cited by 79 · see citing works
Clinical course of acute atrial fibrillation treated with rapid digitalization
WEINER, P., Bassan, M. M., Jarchovsky, J., Iusim, S., & Plavnick, L. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90517-3 · Cited by 69 · see citing works
Conversion of supraventricular arrhythmias to sinus rhythm using flecainide
Goy, J., Grbić, M., Hurni, M., Finci, L., Maendly, R., Duc, J., & Sigwart, U. (1985) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061897 · Cited by 39 · see citing works
Flecainide versus quinidine: Results of a multicenter trial
Hodges, M., Salerno, D. M., & Granrud, G. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90505-8 · Cited by 38 · see citing works
Combined treatment of atrial fibrillation with quinidine and beta-blockers.
Levi, G., & Proto, C. (1972) · Heart · doi:10.1136/hrt.34.9.911 · Cited by 25 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,225 · see citing works
Atrial Fibrillation Begets Atrial Fibrillation
WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500 · see citing works
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström‐Lundqvist, C., Calkins, H. G., Corrado, D., Deftereos, S. G., Diller, G., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz467 · Cited by 1,278 · see citing works
Tieleman, R. G., Gelder, I. C. V., Crijns, H. J. G. M., Kam, P. J. D., van den Berg, M. P., Haaksma, J., van der Woude, H. J., & Allessie, M. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00455-5 · Cited by 401 · see citing works
Verapamil Reduces Tachycardia-Induced Electrical Remodeling of the Atria
Tieleman, R. G., de Langen, C. D. J., Gelder, I. C. V., de Kam, P. J., Grandjean, J. G., Bel, K. J., WIJFFELS, M. C. E. F., Allessie, M. A., & Crijns, H. J. G. M. (1997) · Circulation · doi:10.1161/01.cir.95.7.1945 · Cited by 340 · see citing works
Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria
Polontchouk, L., Haefliger, J., Ebelt, B., Schaefer, T., Stuhlmann, D., Mehlhorn, U., Kuhn‐Régnier, F., de Vivie, E. R., & Dhein, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01443-7 · Cited by 292 · see citing works
SUTTORP, M. J., Kingma, J. H., JESSURUN, E. R., Lie‐A‐Huen, L., van Hemel, N. M., & Lie, K. I. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90326-k · Cited by 282 · see citing works
Electrophysiologic mechanisms of perpetuation of atrial fibrillation
Allessie, M. A., Konings, K., Kirchhof, C. J. H. J., & WIJFFELS, M. C. E. F. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89114-x · Cited by 203 · see citing works
Vos, M. A., Golitsyn, S. R., Stangl, K., Ruda, M. Y., Van Wijk, L., Harry, J. D., Perry, K. T., Touboul, P., Steinbeck, G., & Wellens, H. J. J. (1998) · Heart · doi:10.1136/hrt.79.6.568 · Cited by 200 · see citing works
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188 · see citing works
SUTTORP, M. J., Kingma, J. H., Lie‐A‐Huen, L., & Mast, E. G. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90253-1 · Cited by 176 · see citing works
Intravenous flecainide versus Amiedarone fof recent-onset atrial fibrillation
Donovan, K. D., Power, B. M., Hockings, B. E. F., DOBB, G. J., & Lee, K. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80655-9 · Cited by 167 · see citing works
Comparison of flecainide and procainamide in cardioversion of atrial fibrillation
Madrid, A. H., Moro, C., Marín-Huerta, E., Mestre, J. L., Novo, L., & COSTA, A. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.8.1127 · Cited by 124 · see citing works
Bianconi, L., BOCCADAMO, R., Pappalardo, A., Gentili, C., & Pistolese, M. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90530-4 · Cited by 123 · see citing works
Chyou, J. Y., Barkoudah, E., Dukes, J. W., Goldstein, L. B., Joglar, J. A., Lee, A. M., Lubitz, S. A., Marill, K. A., Sneed, K., Streur, M. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001133 · Cited by 125 · see citing works
Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study
Andrade, J. G., Deyell, M. W., Macle, L., Steinberg, J. S., Glotzer, T. V., Hawkins, N. M., Khairy, P., & Aguilar, M. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac692 · Cited by 117 · see citing works
Spinelli, W., & Hoffman, B. F. (1989) · Circulation Research · doi:10.1161/01.res.65.6.1565 · Cited by 87 · see citing works
Clémenty, J., Dulhoste, M. N., Laiter, C., Denjoy, I., & Santos, P. D. D. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91077-h · Cited by 82 · see citing works
Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide
Donovan, K. D., DOBB, G. J., Coombs, L. J., Lee, K.-Y., Weekes, J. N., Murdock, C. J., & Clarke, G. M. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90435-n · Cited by 71 · see citing works
Bellandi, F., Cantini, F., Pedone, T., Palchetti, R., Bamoshmoosh, M., & Dabizzi, R. P. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181108 · Cited by 62 · see citing works
The effect of magnesium versus verapamil on supraventricular arrhythmias
Gullestad, L. L., Birkeland, K. I., Vanberg, P., Mølstad, P., Høyer, M. M., & KJEKSHUS, J. K. (1993) · Clinical Cardiology · doi:10.1002/clc.4960160512 · Cited by 61 · see citing works
Efficacy of flecainide for the reversion of acute onset atrial fibrillation
Donovan, K. D., DOBB, G. J., Coombs, L. J., Lee, K.-Y., Weekes, J. N., Murdock, C. J., & Clarke, G. M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91078-i · Cited by 56 · see citing works
Inoue, H., Yamashita, T., Nozaki, A., & Sugimoto, T. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90773-3 · Cited by 56 · see citing works
Association of Atrial Fibrillation Episode Duration With Arrhythmia Recurrence Following Ablation
Andrade, J. G., Deyell, M. W., Verma, A., Macle, L., Champagne, J., Leong‐Sit, P., NOVAK, P. G., Badra‐Verdu, M., Sapp, J. L., Khairy, P., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8748 · Cited by 52 · see citing works
Efficacy of flecainide acetate for atrial arrhythmias following coronary artery bypass grafting
Wafa, S., Ward, D. E., Parker, D. J., & Camm, A. J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90078-7 · Cited by 38 · see citing works
Intravenous flecainide acetate for supraventricular tachycardias
Hellestrand, K. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90496-1 · Cited by 38 · see citing works
Doki, K., Homma, M., Kuga, K., Aonuma, K., & Kohda, Y. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03435.x · Cited by 37 · see citing works
Tieleman, R. G., Gelder, I. C. V., Bosker, H. A., Kingma, T., Wilde, A. A. M., Kirchhof, C. J. H. J., Bennekers, J. H., Bracke, F. A. L. E., Veeger, N. J. G. M., Haaksma, J., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2004.11.014 · Cited by 34 · see citing works
Doki, K., Homma, M., Kuga, K., Kusano, K., Watanabe, S., Yamaguchi, I., & Kohda, Y. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0188-x · Cited by 35 · see citing works
Prevention of arrhythmias after noncardiac thoracic operations: Flecainide versus digoxin
Borgeat, A., Petropoulos, P., Cavin, R., Biollaz, J., Munafo, A., & Schwander, D. (1991) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(91)91016-o · Cited by 34 · see citing works
Ganau, G., & Lenzi, T. (1998) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(98)00003-1 · Cited by 31 · see citing works
Gavaghan, T. P., Koegh, A. M., Kelly, R. P., Campbell, T. J., Thorburn, C. W., & Morgan, J. J. (1988) · Heart · doi:10.1136/hrt.60.6.497 · Cited by 30 · see citing works
WIRTH, K. J., & Knobloch, K. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000328 · Cited by 28 · see citing works
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 28 · see citing works
Is There a Future for Antiarrhythmic Drug Therapy?
Guerra, P. G., Talajic, M. R., Roy, D., Dubuc, M., Thibault, B., & Nattel, S. (1998) · Drugs · doi:10.2165/00003495-199856050-00003 · Cited by 25 · see citing works
Flecainide in the Wolff-Parkinson-White syndrome
Crozier, I. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91074-e · Cited by 25 · see citing works
Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity
Doki, K., Sekiguchi, Y., Kuga, K., Aonuma, K., & Homma, M. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2015.04.001 · Cited by 24 · see citing works
Viskin, S., & Belhassen, B. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90176-x · Cited by 23 · see citing works
Santinelli, V., Arnese, M., Oppo, I., Matarazzi, C., MAIONE, S., Palma, M., & Giunta, A. (1993) · CHEST Journal · doi:10.1378/chest.103.4.1068 · Cited by 22 · see citing works
Flecainide acetate for long-term prevention of paroxysmal supraventricular tachyarrhythmias.
Benditt, D. G., Dunnigan, A., Buetikofer, J., & Milstein, S. (1991) · Circulation · doi:10.1161/01.cir.83.1.345 · Cited by 22 · see citing works
Doki, K., Homma, M., Kuga, K., Watanabe, S., Yamaguchi, I., & Kohda, Y. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2004.04.009 · Cited by 21 · see citing works
CYP2D6 genotype affects age-related decline in flecainide clearance
Doki, K., Homma, M., Kuga, K., Aonuma, K., & Kohda, Y. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283588fe5 · Cited by 18 · see citing works
Assessment of serum flecainide trough levels in patients with tachyarrhythmia
Homma, M., Kuga, K., Doki, K., Katori, K., Yamaguchi, I., Sugibayashi, K., & Kohda, Y. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055128 · Cited by 18 · see citing works
Aguilar, M., & Nattel, S. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000271 · Cited by 16 · see citing works
Managing atrial fibrillation in elderly people
English, K. M., & Channer, K. S. (1999) · BMJ · doi:10.1136/bmj.318.7191.1088 · Cited by 15 · see citing works
Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.
Blake, G. E., & Lakkireddy, D. (2008) · Europe PMC (PubMed Central) · doi:10.4022/jafib.45 · Cited by 14 · see citing works
Borgundvaag, B., & Ovens, H. J. (2004) · Canadian Journal of Emergency Medicine · doi:10.1017/s1481803500006849 · Cited by 14 · see citing works
Doki, K., Homma, M., Kuga, K., Aonuma, K., & Kohda, Y. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328361fb8d · Cited by 13 · see citing works
van Wijk, L. M., Crijns, H. J. G. M., van Gilst, W. H., Wesseling, H., & Lie, K. I. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90780-1 · Cited by 12 · see citing works
The acute effects of magnesium in atrial fibrillation and flutter with a rapid ventricular rate
Walker, S., Taylor, J., & Harrod, R. (1996) · Emergency Medicine Australasia · doi:10.1111/j.1442-2026.1996.tb00274.x · Cited by 9 · see citing works
FABER, T. S., & Camm, A. J. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050184 · Cited by 8 · see citing works
Clinical electrophysiologic effects of flecainide acetate
Mehta, D., Camm, A. J., & Ward, D. E. (1988) · Cardiovascular Drugs and Therapy · doi:10.1007/bf02125745 · Cited by 8 · see citing works
High performance liquid chromatography for routine monitoring of serum flecainide
Nakagawa, R., Homma, M., Kuga, K., Yamaguchi, I., Kobayashi, D., Morimoto, Y., & Kohda, Y. (2002) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00224-8 · Cited by 8 · see citing works
Katritsis, D. G., Boriani, G., Cosío, F. G., Jaı̈s, P., Hindricks, G., Josephson, M. E., Keegan, R., Knight, B. P., Kück, K., Lane, D. A., et al. (2016) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:5.3.gl1 · Cited by 7 · see citing works
Obayashi, M., Kosugi, T., Yamazaki, J., Matsumoto, Y., Fukuoka, M., & Matsumoto, M. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00578-7 · Cited by 7 · see citing works
Doki, K., Sekiguchi, Y., Kuga, K., Aonuma, K., Kohda, Y., & Homma, M. (2014) · Biomedical Chromatography · doi:10.1002/bmc.3143 · Cited by 6 · see citing works
Doki, K., Sekiguchi, Y., Kuga, K., Aonuma, K., & Homma, M. (2016) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000239 · Cited by 6 · see citing works
A high performance liquid chromatographic method for the quantitation of flecainide in plasma
Broly, F., Marecaux, P., Houdret, N., Lhermitte, M., & Houssin, R. (1991) · Biomedical Chromatography · doi:10.1002/bmc.1130050604 · Cited by 6 · see citing works
Class IC drugs: Propafenone and flecainide
Puech, P., & Gagnol, J. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00357028 · Cited by 5 · see citing works
van Middendorp, L. B., Strik, M., Houthuizen, P., Kuiper, M., Maessen, J. G., Auricchio, A., & Prinzen, F. W. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000020 · Cited by 5 · see citing works
Krämer, B. K., Mayer, F., Liebich, H. M., Ress, K. M., Kühlkamp, V., Becker, J. U., Risler, T., & Seipel, L. (1988) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(88)80141-5 · Cited by 5 · see citing works
Update on Antiarrhythmic Drugs in Emergency Medicine
Stapczynski, J. S. (1988) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(20)30561-7 · Cited by 4 · see citing works
Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide
Doki, K., Apáti, S., Sakata, T., & Homma, M. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00031 · Cited by 3 · see citing works
Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation or Atrial Flutter to Sinus Rhythm
SUTTORP, M. J., JESSURUN, E. R., & Kingma, J. H. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1816-3_6 · Cited by 3 · see citing works
Update on the Emergent Treatment of Arrhythmias
Stapczynski, J. S. (1988) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(20)30560-5 · Cited by 3 · see citing works
Doki, K., HOMMA, M., Kuga, K., Kawano, S., Aonuma, K., Yamaguchi, I., & Kohda, Y. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00837.x · Cited by 2 · see citing works
The Place of Antiarrhythmic Drugs and Rhythm Control in the Treatment of Atrial Fibrillation
Chevalier, P., & Chief, C. E. (2009) · European Cardiology Review · doi:10.15420/ecr.2009.5.1.36 · Cited by 1 · see citing works
Guhl, E., & Jain, S. K. (2017) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000218
Liu, C., Li, C., Xu, X., Zhou, M., Huang, X., Zhou, B., Cao, J., Huang, S., & Guo, Z. (2023) · Clinical Case Reports · doi:10.1002/ccr3.8202 · Cited by 1 · see citing works
Ectopic Foci Study on the Crest Terminalis in 3D Computer Model of Human Atrial
Villa, C. A. R., Castaño, A. P., Castillo, A., & Heidenreich, E. A. (2012) · Advances in intelligent and soft computing · doi:10.1007/978-3-642-28839-5_18
Hief, C., Klösch, C., Podczeck, A., & Steinbach, K. (1999) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Use of flecainide acetate in the treatment of supraventricular tachyarrhythmias
Marwick, T. H., & Woodhouse, S. P. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91398-7
Attention à l'emploi de la flécaïnide chez l'hémodialysé
Montagnac, R., Schoen, É., Aliouche, C.-P., & Schillinger, F. (2006) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2006.06.005
Electrophysiologic Approach to Patients with Supraventricular Tachycardia
Rubenstein, D. G., & Zaher, C. (1989) · Springer eBooks · doi:10.1007/978-1-4612-3534-7_12
Criteria for Selection of Patients for Internal Atrial Defibrillator Implantations
Capucci, A., Aschieri, D., VILLANI, G. Q., & Rosi, A. (1998) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-5254-9_39
- Authors
- Crozier, I. G., Ikram, H., Kenealy, M., & Levy, L.
- Affiliations
- Princess Margaret Hospital (NZ)
- Corresponding author
- Crozier, Ian G.
- ORCID
- Crozier, Ian G.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1987-03
- Volume
- 59
- Issue
- 6
- Pages
- 607-609
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2002205598
- Cited by
- 76
- References
- 10
- Citations by year
- 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- flecainide, supraventricular tachycardia, conversion to sinus rhythm, intravenous antiarrhythmic therapy, atrial fibrillation, atrioventricular nodal tachycardia, atrial flutter, adverse drug reactions, ventricular tachycardia
- MeSH terms
- Acute Disease, Adolescent, Adult, Aged, Female, Flecainide, Heart Rate, Humans, Infusions, Intravenous, Male, Middle Aged, Tachycardia, Supraventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
